|
|
| Click here for links to all Expanded Tables of Contents |
|
EXPANDED TABLE OF
CONTENTS VOLUME 5, NUMBER 1 JANUARY 2002 |
| TREATMENT HIGHLIGHTS |
| DEMENTIA |
| Caregivers of spouses with dementia are found to be at risk for ongoing negative psychological effects after the death of the impaired spouse. |
| ENURESIS / ENCOPRESIS |
| Knowledge regarding assessment and treatment of enuresis and encopresis is reviewed in a 10-year update. |
| STROKE AND SUICIDE |
| Individuals who have had a stroke are found to be at greater risk for suicide than other people in the general population. |
| DEPRESSION |
| Cognitive-behavioral group therapy is found to reduce the risk of depression in adolescents whose parents have a history of depression. |
| NICOTINE DEPENDENCE AND DEPRESSION |
| Cigarette smokers with a history of major depression who stop smoking are found to be at increased risk of developing a new episode of major depression. |
| OF NOTE |
|
Seeing tobacco use in films is found to be associated with initiation of smoking in adolescents.
People with diabetes are twice as likely to experience depression than similar individuals without diabetes. A preliminary study suggests that sertraline (Zoloft) may be effective in the treatment of generalized anxiety disorder (GAD) in children. In a policy statement recently issued by the American Academy of Pediatrics (AAP) on the impact of media violence on children, it is noted that “extensive research evidence indicates that media violence can contribute to aggressive behavior, desensitization to violence, nightmares, and fear of being harmed.” |
| PSYCHOPHARMACOLOGY NOTE |
| A review of research suggests that small samples may have led to overestimations of the effectiveness of selective serotonin reuptake inhibitors (SSRIs) in the treatment of panic disorder. |
| FDA NEWS AND REVIEW |
|
Approval: Paxil (paroxetine) for the treatment of posttraumatic stress disorder (PTSD)
Product Safety Information: The FDA has issued a warning to consumers to immediately discontinue the use of Lipokinetix, a dietary supplement. |
| ASSESSMENT |
| Strengths and Difficulties Questionnaire (SDQ) |
| RESOURCES |
| Each issue presents descriptions of clinical resources (eg, professional materials, patient handouts) and information on how to receive those materials. |